![Joseph Damasio](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 31/01/2026
Joseph Luis Damasio is currently Chief Financial Officer at Harvard Apparatus Regenerative Technology, Inc. since 2022.
Formerly, Mr. Damasio was Finance Director at Nelipak Corp., Vice President-Finance & Administration at Pressure BioSciences, Inc. in 2012, Chief Financial Officer & VP-Finance at Pressure BioSciences, Inc. from 2017 to 2019, Senior Accountant at BearingPoint, Inc., Auditor at PricewaterhouseCoopers LLP, Controller at XL Hybrids, Inc. from 2019 to 2020, Vice President-Finance at Inhibikase Therapeutics, Inc. from 2021 to 2022, and Controller at Cue Biopharma, Inc. from 2020 to 2021.
Education includes an MBA from Boston College and an undergraduate degree from the University of Massachusetts.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 06/07/2012 | 20 ( -.--% ) | 0 $ | 31/01/2026 | |
| 21/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Direttore Finanziario/CFO | 08/08/2022 |
| Società | Posizione | Fine |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Direttore Finanziario/CFO | 08/08/2022 |
| CUE BIOPHARMA, INC. | Comptroller/Controller/Auditor | 01/10/2021 |
XL Hybrids, Inc.
 XL Hybrids, Inc. Auto Parts: OEMProducer Manufacturing Develops hybrid electric powertrain technology for commercial and municipal fleets | Comptroller/Controller/Auditor | 01/06/2020 |
| PRESSURE BIOSCIENCES, INC. | Direttore Finanziario/CFO | 22/02/2019 |
| PRESSURE BIOSCIENCES, INC. | Direttore Finanziario/CFO | 08/08/2012 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 10 |
|---|---|
Pressure BioSciences, Inc.
 Pressure BioSciences, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes infectious disease diagnostic products | Health Technology |
BearingPoint, Inc.
 BearingPoint, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management and technology consulting services | Commercial Services |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
XL Hybrids, Inc.
XL Hybrids, Inc. Auto Parts: OEMProducer Manufacturing Develops hybrid electric powertrain technology for commercial and municipal fleets | Producer Manufacturing |
Harvard Apparatus Regenerative Technology, Inc.
 Harvard Apparatus Regenerative Technology, Inc. Medical SpecialtiesHealth Technology Engages in the development and commercialization of medical devices | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inhibikase Therapeutics, Inc.
 Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
Nelipak Corp.
 Nelipak Corp. Miscellaneous Commercial ServicesCommercial Services Provides healthcare packaging solutions | Commercial Services |
Cue Biopharma, Inc.
 Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
